Author pages are created from data sourced from our academic publisher partnerships and public sources.
Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.
CONTEXT Large segments of the population at risk for osteoporosis and fracture have not been evaluated, and the usefulness of peripheral measurements for short-term prediction of fracture risk is… Expand
Bone mineral density thresholds for pharmacological intervention to prevent fractures.
BACKGROUND Treatment intervention thresholds for prevention of osteoporotic fractures can be derived from reports from the World Health Organization (diagnostic criteria) and National Osteoporosis… Expand
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
- S. Martino, J. Cauley, +5 authors S. Cummings
- Journal of the National Cancer Institute
- 1 December 2004
BACKGROUND The randomized, double-blind Multiple Outcomes of Raloxifene Evaluation (MORE) trial found that 4 years of raloxifene therapy decreased the incidence of invasive breast cancer among… Expand
Osteoporosis and Fracture Risk in Women of Different Ethnic Groups
- E. Barrett-connor, E. Siris, +5 authors L. Sherwood
- Journal of bone and mineral research : the…
- 18 October 2004
Osteoporosis and 1‐year fracture risk were studied in 197,848 postmenopausal American women from five ethnic groups. Weight explained differences in BMD, except among blacks, who had the highest BMD.… Expand
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.
- E. Barrett-connor, L. Mosca, +5 authors N. Wenger
- The New England journal of medicine
- 1 December 2006
BACKGROUND The effect of raloxifene, a selective estrogen-receptor modulator, on coronary heart disease (CHD) and breast cancer is not established. METHODS We randomly assigned 10,101… Expand
The prevalence of peripheral arterial disease in a defined population.
- M. Criqui, A. Fronek, E. Barrett-connor, M. Klauber, S. Gabriel, D. Goodman
- 1 March 1985
Because patients with peripheral arterial disease (PAD) may be asymptomatic or may present with atypical symptoms or findings, the true population prevalence of PAD is essentially unknown. We used… Expand
Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies
- L. Wang, Y. Song, +11 authors H. Sesso
- Circulation. Cardiovascular quality and outcomes
- 1 November 2012
Background—Vitamin D status has been linked to the risk of cardiovascular disease (CVD). However, the optimal 25-hydroxy-vitamin D (25[OH]-vitamin D) levels for potential cardiovascular health… Expand
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women
- K. Yaffe, T. Blackwell, A. Kanaya, N. Davidowitz, E. Barrett-connor, K. Krueger
- Psychology, Medicine
- 24 August 2004
Objective: To investigate the association between diabetes and impaired fasting glucose (IFG) and cognition and risk of developing both dementia and mild cognitive impairment (MCI) in older women.… Expand
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
- J. Kostis, G. Jackson, +21 authors R. Shabsigh
- The American journal of cardiology
- 15 July 2005
Recent studies have highlighted the relation between erectile dysfunction (ED) and cardiovascular disease. In particular, the role of endothelial dysfunction and nitric oxide in ED and… Expand
Sarcopenia in elderly men and women: the Rancho Bernardo study.
- E. Castillo, D. Goodman-gruen, D. Kritz-Silverstein, D. Morton, D. Wingard, E. Barrett-connor
- American journal of preventive medicine
- 1 October 2003
BACKGROUND Sarcopenia risk factors are poorly understood. METHODS This study examines sarcopenia prevalence and risk factors in community-dwelling men (694) and women (1006) aged 55-98 years… Expand